Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury

Experimental Gerontology

Volumn 46, Issue 9, 2011, Pages 762-767

  Ananthakrishnan, Radha ^a   Li, Qing ^a   Gomes, Teodoro ^a   Schmidt, Ann Marie ^a   Ramasamy, Ravichandran ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging hearts; Aldose reductase; Cardiac function; Myocardial ischemic injury; Polyol pathway

Indexed keywords

ALDEHYDE REDUCTASE; CP 407 711; ENZYME INHIBITOR; IDITOL DEHYDROGENASE; UNCLASSIFIED DRUG; ZOPOLRESTAT;

AGE DISTRIBUTION; AGING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGING; ALDEHYDE REDUCTASE; ANIMALS; BLOTTING, WESTERN; L-IDITOL 2-DEHYDROGENASE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, INBRED F344;

RATTUS;

EID: 79960626595     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2011.05.001     Document Type: Article

References (52)

1. Ananthakrishnan R., Kaneko M., Hwang Y.C., Quadri N., Gomez T., Li Q., Caspersen C., Ramasamy R. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore. The American Journal of Physiology 2009, 296:H333-H341.
2. Azhar G., Gao W., Liu L., Wei J.Y. Ischemia-reperfusion in the adult mouse heart influence of age. Experimental Gerontology 1999, 34:699-714.
3. Azhar G., Liu L., Zhang X., Wei J.Y. Influence of age on hypoxia/reoxygenation-induced DNA fragmentation and bcl-2, bcl-xl, bax and fas in the rat heart and brain. Mechanisms of Ageing and Development 1999, 112:5-25.
4. Boengler K., Schultz R., Heusch G. Loss of cardioprotection with ageing. Cardiovascular Research 2009, 83:247-261.
5. Camici P., Ferrannini E., Opie L.H. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Progress in Cardiovascular Diseases 1989, 32:217-238.
6. Cartee G.D. Myocardial GLUT-4 glucose transporter protein levels of rats decline with advancing age. Journal of Gerontology 1993, 48:B168-B170.
7. Dan Q., Wong R.L., Yin S., Chung S.K., Chung S.S., Lam K.S. Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression. Nephron Experimental Nephrology 2004, 98:e89-e99.
8. Hall J.L., Mazzeo R.S., Podolin D.A., Cartee G.D., Stanley W.C. Exercise training does not compensate for age-related decrease in myocardial GLUT-4 content. Journal of Applied Physiology 1994, 76:328-332.
9. Headrick J.P. Aging impairs functional, metabolic and ionic recovery from ischemia-reperfusion and hypoxia-reoxygenation. Journal of Molecular and Cellular Cardiology 1998, 30:1415-1430.
10. Ho E.C., Lam K.S., Chen Y.S., Yip J.C., Arvindakshan M., Yamagishi S., Yagihashi S., Oates P.J., Ellery C.A., Chung S.S., Chung S.K. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes 2006, 55:1946-1953.
11. Hwang Y.C., Sato S., Tsai J.Y., Yan S., Bakr S., Zhang H., Oates P.J., Ramasamy R. Aldose reductase activation is a key component of myocardial response to ischemia. The FASEB Journal 2002, 16:243-245.
12. Hwang Y.C., Bakr S., Ellery C.A., Oates P.J., Ramasamy R. Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium. The FASEB Journal 2003, 17:2331-2333.
13. Hwang Y.C., Kaneko M., Bakr S., Liao H., Lu Y., Lewis E.R., Yan S., Ii S., Itakura M., Rui L., Skopicki H., Homma S., Schmidt A.M., Oates P.J., Szabolcs M., Ramasamy R. Central role for aldose reductase pathway in myocardial ischemic injury. The FASEB Journal 2004, 18:1192-1199.
14. Hwang Y.C., Shaw S., Kaneko M., Redd H., Marrero M.B., Ramasamy R. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury. The FASEB Journal 2005, 19:795-797.
15. Isoyama S., Nitta-Komatsubara Y. Acute and chronic adaptation to hemodynamic overload and ischemia in the aged heart. Heart Failure Reviews 2002, 7:63-69.
16. Iwata K., Matsuno K., Nishinaka T., Persson C., Yabe-Nishimura C. Aldose reductase inhibitors improve myocardial reperfusion injury in mice by a dual mechanism. Journal of Pharmacological Sciences 2006, 102:37-46.
17. Kaiserova K., Tang X.L., Srivastava S., Bhatnagar A. Role of nitric oxide in regulating aldose reductase activation in the ischemic heart. The Journal of Biological Chemistry 2008, 283:9101-9112.
18. Kates A.M., Herrero P., Dence C., Soto P., Srinivasan M., Delano D.G., Ehsani A., Gropler R.J. Impact of aging on substrate metabolism by the human heart. Journal of the American College of Cardiology 2003, 41:293-299.
19. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003, 107:490-497.
20. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation 2003, 107:139-146.
21. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003, 107:346-354.
22. Lesnefsky E.J., Gallo D.S., Ye J., Whittingham T.S., Lust W.D. Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart. The Journal of Laboratory and Clinical Medicine 1994, 124:843-851.
23. Li Q., Hwang Y.C., Ananthakrishnan R., Oates P.J., Guberski D., Ramasamy R. Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts. Cardiovascular Diabetology 2008, 7:33.
24. Liu P., Xu B., Cavalieri T.A., Hock C.E. Age-related difference in myocardial function and inflammation in a rat model of myocardial ischemia-reperfusion. Cardiovascular Research 2002, 56:443-453.
25. Lopaschuk G.D., Stanley W.C. Glucose metabolism in the ischemic heart. Circulation 1997, 95:313-315.
26. Lopaschuk G.D., Wall S.R., Olley P.M., Davies N.J. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circulation Research 1988, 63:1036-1043.
27. McMillin J.B., Taffet G.E., Taegtmeyer H., Hudson E.K., Tate C.A. Mitochondrial metabolism and substrate competition in the aging Fischer rat heart. Cardiovascular Research 1993, 27:2222-2228.
28. Misare B.D., Krukenkamp I.B., Levitsky S. Age-dependent sensitivity to unprotected cardiac ischemia: the senescent myocardium. The Journal of Thoracic and Cardiovascular Surgery 1992, 103:60-64. discussion 64-65.
29. Mylari B.L., Larson E.R., Beyer T.A., Zembrowski W.J., Aldinger C.E., Dee M.F., Siegel T.W., Singleton D.H. Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners. Journal of Medicinal Chemistry 1991, 34:108-122.
30. Mylari B.L., Withbroe G.J., Beebe D.A., Brackett N.S., Conn E.L., Coutcher J.B., Oates P.J., Zembrowski W.J. Design and synthesis of a novel family of triazine-based inhibitors of sorbitol dehydrogenase with oral activity: 1-[4-[3R,5S-dimethyl-4-(4-methyl-[1,3,5]triazin-2-yl)-piperazin-1-yl]-[1,3,5]triazin-2-yl]-(R) ethanol. Bioorganic & Medicinal Chemistry 2003, 11:4179-4188.
31. Nakamura N., Obayashi H., Fujii M., Fukui M., Yoshimori K., Ogata M., Hasegawa G., Shigeta H., Kitagawa Y., Yoshikawa T., Kondo M., Ohta M., Nishimura M., Nishinaka T., Nishimura C.Y. Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products. Free Radical Biology & Medicine 2000, 29:17-25.
32. Neely J.R., Morgan H.E. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annual Review of Physiology 1974, 36:413-459.
33. Ramana K.V., Willis M.S., White M.D., Horton J.W., DiMaio J.M., Srivastava D., Bhatnagar A., Srivastava S.K. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 2006, 114:1838-1846.
34. Ramasamy R., Oates P.J., Schaefer S. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes 1997, 46:292-300.
35. Ramasamy R., Trueblood N., Schaefer S. Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion. The American Journal of Physiology 1998, 275:H195-H203.
36. Ramasamy R., Liu H., Oates P.J., Schaefer S. Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat. Cardiovascular Research 1999, 42:130-139.
37. Ramasamy R., Hwang Y.C., Whang J., Bergmann S.R. Protection of ischemic hearts by high glucose is mediated, in part, by GLUT-4. The American Journal of Physiology 2001, 281:H290-H297.
38. Schaefer S., Carr L.J., Prussel E., Ramasamy R. Effects of glycogen depletion on ischemic injury in isolated rat hearts: insights into preconditioning. The American Journal of Physiology 1995, 268:H935-H944.
39. Shinmura K., Bolli R., Liu S.Q., Tang X.L., Kodani E., Xuan Y.T., Srivastava S., Bhatnagar A. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circulation Research 2002, 91:240-246.
40. Stanley W.C., Lopaschuk G.D., Hall J.L., McCormack J.G. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovascular Research 1997, 33:243-257.
41. Steenbergen C., Murphy E., Watts J.A., London R.E. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circulation Research 1990, 66:135-146.
42. Steenbergen C., Perlman M.E., London R.E., Murphy E. Mechanism of preconditioning. Ionic alterations. Circulation Research 1993, 72:112-125.
43. Taegtmeyer H., King L.M., Jones B.E. Energy substrate metabolism, myocardial ischemia, and targets for pharmacotherapy. The American Journal of Cardiology 1998, 82:54K-60K.
44. Tang W.H., Wu S., Wong T.M., Chung S.K., Chung S.S. Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart. Free Radical Biology & Medicine 2008, 45:602-610.
45. Tracey W.R., Magee W.P., Ellery C.A., MacAndrew J.T., Smith A.H., Knight D.R., Oates P.J. Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury. The American Journal of Physiology 2000, 279:H1447-H1452.
46. Trueblood N., Ramasamy R. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. The American Journal of Physiology 1998, 275:H75-H83.
47. Vanoverschelde J.L., Janier M.F., Bergmann S.R. The relative importance of myocardial energy metabolism compared with ischemic contracture in the determination of ischemic injury in isolated perfused rabbit hearts. Circulation Research 1994, 74:817-828.
48. Vikramadithyan R.K., Hu Y., Noh H.L., Liang C.P., Hallam K., Tall A.R., Ramasamy R., Goldberg I.J. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. The Journal of Clinical Investigation 2005, 115:2434-2443.
49. Wei J.Y. Age and the cardiovascular system. The New England Journal of Medicine 1992, 327:1735-1739.
50. Willems L., Zatta A., Holmgren K., Ashton K.J., Headrick J.P. Age-related changes in ischemic tolerance in male and female mouse hearts. Journal of Molecular and Cellular Cardiology 2005, 38:245-256.
51. Williamson J.R., Chang K., Frangos M., Hasan K.S., Ido Y., Kawamura T., Nyengaard J.R., van den Enden M., Kilo C., Tilton R.G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993, 42:801-813.
52. Young L.H., Renfu Y., Russell R., Hu X., Caplan M., Ren J., Shulman G.I., Sinusas A.J. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 1997, 95:415-422.